You guys crack me up. I love how we're all invested in a company that we refer to as a POS. Kinda funny. Anyway, I'm with you on that. I think this makes a lot of sense for AZN. They take the cash, the royalties for Vimovo and Treximent...plus full right to the stroke/heart attack program.
I just think the recent conference call to update shareholders before the quarterly earnings release was odd. To discuss partnering out a program and the "true value" of the company is just odd. It almost seems as if a discussion is underway and Pozen needs to be able to justify a higher valuation. I saw $6 gets this done.